According to recent filings covering the 90 days ending February 07, 2026, the three most significant insider holders at Zevra Therapeutics are TenPercentOwner Samuel J Braun (3.07Mn shares), President And Ceo Neil F. Mcfarlane (364.35K shares), Other R. Laduane Clifton (143.51K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Samuel J Braun | 3,070,000 | 17 May, 2021 | |
| Neil F. Mcfarlane | President And Ceo | 364,350 | 02 Feb, 2026 |
| R. Laduane Clifton | 143,515 | 07 Jan, 2026 | |
| Joshua Schafer | Cco | 62,278 | 04 Feb, 2026 |
| Travis C Mickle | President & Ceo | 50,555 | 25 May, 2022 |
| Rahsaan Thompson | Chief Legal & Compliance | 49,919 | 02 Feb, 2026 |
| John B Bode | 45,000 | 20 Aug, 2025 | |
| Richard W Pascoe | Chief Executive Officer | 29,973 | 13 Mar, 2023 |
| Timothy J. Sangiovanni | Svp And Finance & Corp Controller | 29,590 | 04 Feb, 2026 |
| Thomas Anderson | 20,000 | 16 Jul, 2024 | |
| Alvin Shih | 20,000 | 15 Sep, 2025 | |
| Matthew R Plooster | 18,500 | 13 Mar, 2023 | |
| David S Tierney | 10,835 | 13 Mar, 2023 | |
| Adrian W Quartel | Chief Medical Officer | 9,723 | 02 Feb, 2026 |
| Tamara A Favorito | 3,894 | 16 Sep, 2025 | |
| Corey Michael Watton | 1,800 | 31 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Feb, 2026 | Timothy J. Sangiovanni | Common Stock | D | 3,000 | $9.18 | 29,590 | D | S |
| 03 Feb, 2026 | Joshua Schafer | Common Stock | D | 10,500 | $9.19 | 62,278 | D | S |
| 02 Feb, 2026 | Neil F. Mcfarlane | Common Stock | D | 91,000 | $9.38 | 364,350 | D | S |
| 31 Jan, 2026 | Neil F. Mcfarlane | Common Stock | A | 233,334 | - | 455,350 | D | M |
| 31 Jan, 2026 | Timothy J. Sangiovanni | Common Stock | A | 11,666 | - | 32,590 | D | M |
| 31 Jan, 2026 | Joshua Schafer | Common Stock | A | 35,334 | - | 72,778 | D | M |
| 30 Jan, 2026 | Timothy J. Sangiovanni | Common Stock | A | 6,333 | - | 22,674 | D | M |
| 30 Jan, 2026 | Timothy J. Sangiovanni | Common Stock | D | 1,750 | $8.82 | 20,924 | D | S |
| 30 Jan, 2026 | Rahsaan Thompson | Common Stock | D | 4,080 | $8.83 | 49,919 | D | S |
| 30 Jan, 2026 | Rahsaan Thompson | Common Stock | A | 11,333 | - | 53,999 | D | M |
| 30 Jan, 2026 | Adrian W Quartel | Common Stock | D | 4,533 | $8.83 | 9,723 | D | S |
| 30 Jan, 2026 | Adrian W Quartel | Common Stock | A | 11,333 | - | 14,256 | D | M |
| 30 Jan, 2026 | Joshua Schafer | Common Stock | A | 11,333 | - | 40,819 | D | M |
| 30 Jan, 2026 | Joshua Schafer | Common Stock | D | 3,375 | $8.83 | 37,444 | D | S |
| 31 Dec, 2025 | R. Laduane Clifton | - | - | 143,515 | D | |||
| 31 Dec, 2025 | R. Laduane Clifton | Common Stock | A | 140,667 | $0.00 | 192,028 | D | M |
| 31 Dec, 2025 | R. Laduane Clifton | Common Stock | D | 48,513 | $8.96 | 143,515 | D | F |
| 31 Dec, 2025 | R. Laduane Clifton | - | - | 192,028 | D | |||
| 10 Oct, 2025 | Neil F. Mcfarlane | Common Stock | A | 50,000 | - | 241,516 | D | M |
| 10 Oct, 2025 | Neil F. Mcfarlane | Common Stock | D | 19,500 | $10.82 | 222,016 | D | S |